Hospital and General Practice in the Management of Rheumatoid Arthritis SIR-I was interested to read the paper by Helliwell and O'Hara [1] on the audit of shared care between hospital and general practice in the management of rheumatoid arthritis (RA) using disease-modifying drugs. They point out that the audit for i.m. gold (sodium aurothiomalate) was disappointing because in only 26% of cases had the standard monitoring protocol been followed, and this poor result was attributed to not carrying out an annual chest X-ray as per protocol. The protocol was followed in 93% of cases for methotrexate, yet their protocol did not include an initial chest X-ray.
